Physician profile
Bridget Robledo
NPI 1841297652
$1,219.61
in general payments reported to CMS, 2019-2025
19 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $14.72 · 2021: $258 · 2022: $237 · 2023: $136 · 2024: $224 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $236.01 | 2021-2025 | Qulipta |
| Lilly USA, LLC | $165.61 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Pharmaceuticals Lp | $130.54 | 2019-2025 | Airsupra, Breztri |
| Acadia Pharmaceuticals INC | $98.09 | 2024-2025 | Daybue |
| Biohaven Pharmaceutical Holding Company Ltd. | $93.19 | 2022 | |
| Novo Nordisk INC | $87.70 | 2019-2024 | Rybelsus |
| Merck Sharp & Dohme LLC | $63.37 | 2021-2022 | |
| Glaxosmithkline, LLC. | $53.22 | 2021-2024 | Arexvy, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $52.52 | 2019 | |
| Exact Sciences Corporation | $33.69 | 2023-2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $31.56 | 2019-2024 | |
| Amgen INC. | $30.63 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.65 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.12 | 2019-2024 | Glassia |
| Inspire Medical Systems, INC. | $24.37 | 2025 | Inspire |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $19.00 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $15.65 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.68 | 2023 | Austedo Xr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Robledo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.